Last reviewed · How we verify

NCT06910865: CRHE

Study of the Radio-clinical Correlation of Endolymphatic Hydrops

Recruiting now Last updated 4 April 2025
What this trial tests

trial in Endolymphatic Hydrops in 100 participants. Currently enrolling.

Timeline
19 July 2024
Primary endpoint
19 December 2025
19 December 2025

Quick facts

Lead sponsorUniversity Hospital, Strasbourg, France
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date19 July 2024
Primary completion19 December 2025
Estimated completion19 December 2025
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Strasbourg, France

Who can join

18 and older, any sex, with Endolymphatic Hydrops. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patients presenting with symptoms of endolymphatic hydrops, signs of vestibular dilation are often found on MRI. Some patients present with these radiological signs without vestibular clinical signs, or signs other than those of hydrops. No study has yet investigated the radiological-clinical correlation of endolymphatic hydrops by selecting patients based on their imaging findings and then comparing them to the symptoms presented.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06910865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing